Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BeOne Medicines Ltd.ONC · Entity 2168 | Principal Accounting Officer | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BeOne Medicines Ltd.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-09-01 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-09-01 · Sale · Disposed 132 · Balance 0 F1: Each American Depositary Share represents 13 Ordinary Shares. F2: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of August 31, 2023, subject to continued service. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 97,929 |
Reported balance
Holding disclosure · report date 2026-09-01 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 97,929 |
Filing footnotes · ownership attribution and instrument terms
F1: Each American Depositary Share represents 13 Ordinary Shares.
F2: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of August 31, 2023, subject to continued service.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CARLISLE COMPANIES INC
Report date February 12, 2021 · Filed February 18, 2021
Section 16 reporting ended · disclosed 2021-02-18. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2026 Filed Sep 3, 2026 21:17 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 132 | $355.86 | $46,973.52 |
DisclosureSEC source: 0001675628-26-000003 · wk-form4_1788470233.xml · nonDerivative · entry 2 Ball Titus B. · CIK 0001675628 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of August 31, 2023, subject to continued service. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 21:55 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 120 | $257.53 | $30,903.60 |
DisclosureSEC source: 0001675628-26-000002 · wk-form4_1781560533.xml · nonDerivative · entry 3 Ball Titus B. · CIK 0001675628 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 21:55 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 49 | $256.39 | $12,562.96 |
DisclosureSEC source: 0001675628-26-000002 · wk-form4_1781560533.xml · nonDerivative · entry 2 Ball Titus B. · CIK 0001675628 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 21:55 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | GrantOrdinary Shares | 31,213 | $0.00 | $0.00 |
DisclosureSEC source: 0001675628-26-000002 · wk-form4_1781560533.xml · nonDerivative · entry 1 Ball Titus B. · CIK 0001675628 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,645 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 11, 2026, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:27 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 36 | $272.08 | $9,794.88 |
DisclosureSEC source: 0001675628-26-000001 · wk-form4_1781126839.xml · nonDerivative · entry 3 Ball Titus B. · CIK 0001675628 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.00 to $272.24, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:27 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 100 | $271.06 | $27,105.76 |
DisclosureSEC source: 0001675628-26-000001 · wk-form4_1781126839.xml · nonDerivative · entry 2 Ball Titus B. · CIK 0001675628 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $271.00 to $271.48, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 21:29 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 122 | $326.76 | $39,864.72 |
DisclosureSEC source: 0001628280-25-041684 · wk-form4_1757021392.xml · nonDerivative · entry 2 Ball Titus B. · CIK 0001675628 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of August 31, 2023, subject to continued service. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 21:51 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | SaleAmerican Depositary Shares | 134 | $258.36 | $34,620.05 |
DisclosureSEC source: 0001651308-25-000110 · wk-form4_1749765082.xml · nonDerivative · entry 2 Ball Titus B. · CIK 0001675628 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 21:51 UTC | BeOne Medicines Ltd. ONC · Entity 2168 | GrantOrdinary Shares | 29,601 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-25-000110 · wk-form4_1749765082.xml · nonDerivative · entry 1 Ball Titus B. · CIK 0001675628 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,983 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 21:40 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | SaleAmerican Depositary Shares | 137 | $189.94 | $26,021.96 |
DisclosureSEC source: 0001651308-24-000111 · wk-form4_1725572424.xml · nonDerivative · entry 2 Ball Titus B. · CIK 0001675628 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of August 31, 2023, subject to continued service. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:05 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantShare Option (Right to Buy) · Derivative | 15,340 | $0.00 Strike: $12.23 | $0.00 |
DisclosureSEC source: 0001651308-24-000069 · wk-form4_1717794316.xml · derivative · entry 2 Ball Titus B. · CIK 0001675628 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,340 Underlying: Ordinary Shares · 15,340 shares Expires 2034-06-04 F2 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F2 · shares: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares. F3 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 21:05 UTC | BeOne Medicines Ltd. BGNE · Entity 2168 | GrantOrdinary Shares | 24,427 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-24-000069 · wk-form4_1717794316.xml · nonDerivative · entry 1 Ball Titus B. · CIK 0001675628 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,905 F1 · security: Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 5, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events. Read SEC document |
| February 02, 2021 Filed Feb 3, 2021 21:25 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | GrantEmployee Stock Option (Right to Buy) · Derivative | 2,355 | $0.00 Strike: $150.00 | $0.00 |
DisclosureSEC source: 0000790051-21-000061 · wf-form4_161238749348536.xml · derivative · entry 2 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,355 Underlying: Common Stock · 2,355 shares Expires 2031-02-01 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning on February 2, 2022. Read SEC document |
| February 02, 2021 Filed Feb 3, 2021 21:25 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | GrantCommon Stock | 505 | $0.00 | $0.00 |
DisclosureSEC source: 0000790051-21-000061 · wf-form4_161238749348536.xml · nonDerivative · entry 1 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,196 F1 · shares: Represents a grant of 505 restricted shares from the issuer for services as an executive officer of the issuer. F2 · balance_after: Includes 48 shares acquired in the issuer's defined contribution plan during the prior year. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 20:07 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | Tax withholdingCommon Stock | 487 | $156.18 | $76,059.66 |
DisclosureSEC source: 0000790051-21-000020 · wf-form4_160987721385860.xml · nonDerivative · entry 2 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,643 F3 · shares: Shares retained to satisfy the reporting person's withholding tax obligation with regards to the above referenced performance share grant and the vesting of previously awarded restricted shares. Read SEC document |
| January 01, 2021 Filed Jan 5, 2021 20:07 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | GrantCommon Stock | 984 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000790051-21-000020 · wf-form4_160987721385860.xml · nonDerivative · entry 1 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,130 F1 · shares: Represents a grant of 984 performance shares from the issuer for services as an executive officer of the issuer. F2 · price: Not applicable. Read SEC document |
| February 04, 2020 Filed Feb 5, 2020 23:45 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | GrantEmployee Stock Option (Right to Buy) · Derivative | 2,475 | $0.00 Strike: $161.41 | $0.00 |
DisclosureSEC source: 0000790051-20-000034 · wf-form4_158094632018224.xml · derivative · entry 2 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,475 Underlying: Common Stock · 2,475 shares Expires 2030-02-03 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning on February 4, 2021. Read SEC document |
| February 04, 2020 Filed Feb 5, 2020 23:45 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | GrantCommon Stock | 455 | $0.00 | $0.00 |
DisclosureSEC source: 0000790051-20-000034 · wf-form4_158094632018224.xml · nonDerivative · entry 1 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,146 F1 · shares: Represents a grant of 455 restricted shares from the issuer for services as an executive officer of the issuer. F2 · balance_after: Includes 55 shares acquired in the issuer's defined contribution plan during the prior year. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 00:13 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | Tax withholdingCommon Stock | 388 | $161.84 | $62,793.92 |
DisclosureSEC source: 0000790051-20-000002 · wf-form4_157801040611817.xml · nonDerivative · entry 2 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,636 Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 00:13 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | GrantCommon Stock | 755 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000790051-20-000002 · wf-form4_157801040611817.xml · nonDerivative · entry 1 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,024 F1 · shares: Represents a grant of 755 performance shares from the issuer for services as an executive officer of the issuer. F2 · price: Not applicable. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 22:01 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | GrantEmployee Stock Option (Right to Buy) · Derivative | 3,185 | $0.00 Strike: $110.79 | $0.00 |
DisclosureSEC source: 0000790051-19-000052 · wf-form4_154949049138008.xml · derivative · entry 2 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,185 Underlying: Common Stock · 3,185 shares Expires 2029-02-04 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning on February 5, 2020. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 22:01 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | GrantCommon Stock | 605 | $0.00 | $0.00 |
DisclosureSEC source: 0000790051-19-000052 · wf-form4_154949049138008.xml · nonDerivative · entry 1 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,269 F1 · shares: Represents a grant of 605 restricted shares from the issuer for services as an executive officer of the issuer. F2 · balance_after: Includes 62 shares acquired in the issuer's defined contribution plan during the prior year and excludes 7 shares disposed of previously for fees incurred in connection with an account holding the issuer's shares. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 22:31 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | Tax withholdingCommon Stock | 304 | $100.52 | $30,558.08 |
DisclosureSEC source: 0000790051-19-000012 · wf-form4_154655467916680.xml · nonDerivative · entry 2 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,609 Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 22:31 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | GrantCommon Stock | 282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000790051-19-000012 · wf-form4_154655467916680.xml · nonDerivative · entry 1 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,913 F1 · shares: Represents a grant of 282 performance shares from the issuer for services as an executive officer of the issuer. F2 · price: Not applicable. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 00:34 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | GrantEmployee Stock Option (Right to Buy) · Derivative | 2,370 | $0.00 Strike: $108.72 | $0.00 |
DisclosureSEC source: 0000790051-18-000070 · wf-form4_151805005152495.xml · derivative · entry 2 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,370 Underlying: Common Stock · 2,370 shares Expires 2028-02-05 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning on February 6, 2019. Read SEC document |
| February 06, 2018 Filed Feb 8, 2018 00:34 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | GrantCommon Stock | 515 | $0.00 | $0.00 |
DisclosureSEC source: 0000790051-18-000070 · wf-form4_151805005152495.xml · nonDerivative · entry 1 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,631 F1 · shares: Represents a grant of 515 restricted shares from the issuer for services as an executive officer of the issuer. F2 · balance_after: Includes 56 shares acquired in the issuer's defined contribution plan during the prior year. Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 20:17 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | Tax withholdingCommon Stock | 228 | $113.65 | $25,912.20 |
DisclosureSEC source: 0000790051-18-000012 · wf-form4_151501064238959.xml · nonDerivative · entry 2 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,060 Read SEC document |
| December 31, 2017 Filed Jan 3, 2018 20:17 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | GrantCommon Stock | 248 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000790051-18-000012 · wf-form4_151501064238959.xml · nonDerivative · entry 1 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,288 F1 · shares: Grant of 248 performance shares. F2 · price: Not applicable. Read SEC document |
| February 08, 2017 Filed Feb 9, 2017 22:48 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | GrantCommon Stock Options · Derivative | 1,790 | $0.00 Strike: $107.73 | $0.00 |
DisclosureSEC source: 0001179110-17-002094 · edgar.xml · derivative · entry 2 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,790 Underlying: Common Stock · 1,790 shares Expires 2027-02-07 F4 · security: Right to buy. F5 · derivative.exercise_date: 597 options exercisable on each of February 8, 2018 and February 8, 2019 and 596 options exercisable on February 8, 2020, cumulatively. Read SEC document |
| February 08, 2017 Filed Feb 9, 2017 22:48 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | GrantCommon Stock | 415 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-002094 · edgar.xml · nonDerivative · entry 1 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,040 F1 · shares: Grant of 415 restricted shares. F2 · price: Not applicable. F3 · balance_after: Includes 17 shares acquired in the issuer's defined contribution plan during the prior year. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 23:00 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | Tax withholdingCommon Stock | 432 | $110.29 | $47,645.28 |
DisclosureSEC source: 0001179110-17-000332 · edgar.xml · nonDerivative · entry 2 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,608 Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 23:00 UTC | CARLISLE COMPANIES INC CSL · Entity 982 | GrantCommon Stock | 576 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-000332 · edgar.xml · nonDerivative · entry 1 Ball Titus B. · CIK 0001675628 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,040 F1 · shares: Grant of 576 performance shares. F2 · price: Not applicable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.